Trial Information
A Comparison Study of Contrast Enhanced Breast CT With MRI On Known Malignancies For Detection of Multifocal/Multicentric Disease
See above
Inclusion Criteria
3.1 Eligibility Criteria All subjects will be women at least 35 years of age that have
been diagnosed with breast cancer and have undergone breast MR imaging for detection of
multifocal/multicentric disease.
3.2 Ineligibility Criteria
- Subject does not meet any of the inclusion criteria
- Women with suspected or confirmed pregnancy
- Women who have had bilateral mastectomy
- Women who are very frail and unable to cooperate
- Women who cannot give informed consent
- Male subjects
- Women with implants
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Principal Investigator
Ioannis Sechopoulos, PhD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Emory University
Authority:
United States: Food and Drug Administration
Study ID:
14357
NCT ID:
NCT00957099
Start Date:
June 2009
Completion Date:
January 2012
Related Keywords:
- Breast Cancer
- Breast Neoplasms
Name | Location |
Emory University Hospital Breast Imaging Center |
Atlanta, Georgia 30322 |